Načítá se...
Patient-reported outcome measures in inherited retinal degeneration gene therapy trials
Patient-reported outcome (PRO) measures have the potential to uniquely capture patient experience and serve as an outcome measure in inherited retinal degeneration (IRD) gene therapy trials. An IRD-specific patient-reported outcome measure may yield valuable information that has not been obtained fr...
Uloženo v:
| Vydáno v: | Ophthalmic Genet |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7110960/ https://ncbi.nlm.nih.gov/pubmed/32100594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13816810.2020.1731836 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|